Literature DB >> 21920670

Smad ubiquitination regulatory factor 2 expression is enhanced in hypertrophic scar fibroblasts from burned children.

Zhi Zhang1, Celeste C Finnerty, Jing He, David N Herndon.   

Abstract

Transforming growth factor-β1 (TGF-β1) plays a key role in hypertrophic scar formation. A lot of studies have shown that TGF-β1 stimulates fibroblast proliferation, collagen production, and α-smooth muscle actin (α-SMA) expression, inhibits matrix degradation and eventually leads to scar formation. Smad proteins are important intracellular mediators of TGF-β1 signaling, and Smad ubiquitination regulatory factor 2 (Smurf2), an ubiquitin ligase for Smads, plays critical roles in the regulation of TGF-β1/Smad signaling. It was reported that Smurf2 was abnormally expressed during the process of liver fibrosis and lung fibrosis. Hypertrophic scarring is a fibroproliferative disorder of the dermis that occurs following wounding. However, little is known about the expression of Smurf2 in hypertrophic scarring. We hypothesized that TGF-β1 signaling cannot be disrupted after wound epithelialization probably due to abnormal expression of Smurf2 in hypertrophic scar fibroblasts. In the present study, we found that hypertrophic scar fibroblasts exhibited increased Smurf2 protein and mRNA levels compared with normal fibroblasts, and the expression of Smurf2 gradually increased in hypertrophic scar fibroblasts after TGF-β1 stimulation. Furthermore, we transfected Smurf2 siRNA into hypertrophic scar fibroblasts, and we found that silencing the expression of Smurf2 in hypertrophic scar fibroblasts dramatically reduced TGF-β1 production, inhibited TGF-β1-induced α-SMA expression and inhibited TGF-β1-induced collagen I synthesis. Our results suggest that the enhanced expression of Smurf2 is involved in the progression of hypertrophic scarring. Copyright Â
© 2011 Elsevier Ltd and ISBI. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21920670      PMCID: PMC3576018          DOI: 10.1016/j.burns.2011.08.012

Source DB:  PubMed          Journal:  Burns        ISSN: 0305-4179            Impact factor:   2.744


  44 in total

Review 1.  Myofibroblasts and mechano-regulation of connective tissue remodelling.

Authors:  James J Tomasek; Giulio Gabbiani; Boris Hinz; Christine Chaponnier; Robert A Brown
Journal:  Nat Rev Mol Cell Biol       Date:  2002-05       Impact factor: 94.444

Review 2.  Mechanisms of TGF-beta signaling from cell membrane to the nucleus.

Authors:  Yigong Shi; Joan Massagué
Journal:  Cell       Date:  2003-06-13       Impact factor: 41.582

Review 3.  Altered negative regulation of transforming growth factor beta signaling in scleroderma: potential involvement of SMURF2 in disease.

Authors:  Michael J Zuscik; Randy N Rosier; Edward M Schwarz
Journal:  Arthritis Rheum       Date:  2003-07

Review 4.  How cells read TGF-beta signals.

Authors:  J Massagué
Journal:  Nat Rev Mol Cell Biol       Date:  2000-12       Impact factor: 94.444

5.  Interaction of smad3 with a proximal smad-binding element of the human alpha2(I) procollagen gene promoter required for transcriptional activation by TGF-beta.

Authors:  S J Chen; W Yuan; S Lo; M Trojanowska; J Varga
Journal:  J Cell Physiol       Date:  2000-06       Impact factor: 6.384

6.  Hypertrophic scar tissues and fibroblasts produce more transforming growth factor-beta1 mRNA and protein than normal skin and cells.

Authors:  R Wang; A Ghahary; Q Shen; P G Scott; K Roy; E E Tredget
Journal:  Wound Repair Regen       Date:  2000 Mar-Apr       Impact factor: 3.617

7.  TGF-beta induces assembly of a Smad2-Smurf2 ubiquitin ligase complex that targets SnoN for degradation.

Authors:  S Bonni; H R Wang; C G Causing; P Kavsak; S L Stroschein; K Luo; J L Wrana
Journal:  Nat Cell Biol       Date:  2001-06       Impact factor: 28.824

8.  Downregulation of Smad transcriptional corepressors SnoN and Ski in the fibrotic kidney: an amplification mechanism for TGF-beta1 signaling.

Authors:  Junwei Yang; Xianghong Zhang; Yingjian Li; Youhua Liu
Journal:  J Am Soc Nephrol       Date:  2003-12       Impact factor: 10.121

Review 9.  Smad-dependent and Smad-independent pathways in TGF-beta family signalling.

Authors:  Rik Derynck; Ying E Zhang
Journal:  Nature       Date:  2003-10-09       Impact factor: 49.962

Review 10.  Smad regulation in TGF-beta signal transduction.

Authors:  A Moustakas; S Souchelnytskyi; C H Heldin
Journal:  J Cell Sci       Date:  2001-12       Impact factor: 5.285

View more
  12 in total

Review 1.  The complexity of TGFβ/activin signaling in regeneration.

Authors:  René Fernando Abarca-Buis; Edna Ayerim Mandujano-Tinoco; Alejandro Cabrera-Wrooman; Edgar Krötzsch
Journal:  J Cell Commun Signal       Date:  2021-01-22       Impact factor: 5.782

2.  Preliminary study of the effect of abnormal savda munziq on TGF-β1 and Smad7 expression in hypertrophic scar fibroblasts.

Authors:  Hujun Wang; Weicheng Gao; Menglong Kong; Nan Li; Shaolin Ma
Journal:  Int J Clin Exp Med       Date:  2015-01-15

3.  The P50 Research Center in Perioperative Sciences: How the investment by the National Institute of General Medical Sciences in team science has reduced postburn mortality.

Authors:  Celeste C Finnerty; Karel D Capek; Charles Voigt; Gabriel Hundeshagen; Janos Cambiaso-Daniel; Craig Porter; Linda E Sousse; Amina El Ayadi; Ramon Zapata-Sirvent; Ashley N Guillory; Oscar E Suman; David N Herndon
Journal:  J Trauma Acute Care Surg       Date:  2017-09       Impact factor: 3.313

Review 4.  The Ubiquitin Proteasome System and Skin Fibrosis.

Authors:  Wanlu Shen; Zhigang Zhang; Jiaqing Ma; Di Lu; Lechun Lyu
Journal:  Mol Diagn Ther       Date:  2021-01-12       Impact factor: 4.074

5.  Puerarin inhibits cardiac fibrosis via monocyte chemoattractant protein (MCP)-1 and the transforming growth factor-β1 (TGF-β1) pathway in myocardial infarction mice.

Authors:  Zhiwen Tao; Yingbin Ge; Ningtian Zhou; Yunle Wang; Weili Cheng; Zhijian Yang
Journal:  Am J Transl Res       Date:  2016-10-15       Impact factor: 4.060

6.  Effect of N-(2-aminoethyl) ethanolamine on hypertrophic scarring changes in vitro: Finding novel anti-fibrotic therapies.

Authors:  Zhenping Chen; Jianhua Gu; Amina El Ayadi; Andres F Oberhauser; Jia Zhou; Linda E Sousse; Celeste C Finnerty; David N Herndon; Paul J Boor
Journal:  Toxicol Appl Pharmacol       Date:  2018-09-22       Impact factor: 4.219

7.  β-Adrenergic Receptor Trafficking, Degradation, and Cell Surface Expression Are Altered in Dermal Fibroblasts from Hypertrophic Scars.

Authors:  Amina El Ayadi; Anesh Prasai; Ye Wang; David N Herndon; Celeste C Finnerty
Journal:  J Invest Dermatol       Date:  2018-02-22       Impact factor: 8.551

8.  Effect of P144® (Anti-TGF-β) in an "In Vivo" Human Hypertrophic Scar Model in Nude Mice.

Authors:  Shan Shan Qiu; Javier Dotor; Bernardo Hontanilla
Journal:  PLoS One       Date:  2015-12-31       Impact factor: 3.240

9.  Coordinate activities of BRD4 and CDK9 in the transcriptional elongation complex are required for TGFβ-induced Nox4 expression and myofibroblast transdifferentiation.

Authors:  Talha Ijaz; Mohammad Jamaluddin; Yingxin Zhao; Yueqing Zhang; Jayson Jay; Celeste C Finnerty; David N Herndon; Ronald G Tilton; Allan R Brasier
Journal:  Cell Death Dis       Date:  2017-02-09       Impact factor: 8.469

10.  The IL-6 trans-signaling-STAT3 pathway mediates ECM and cellular proliferation in fibroblasts from hypertrophic scar.

Authors:  Sutapa Ray; Xiaoxi Ju; Hong Sun; Celeste C Finnerty; David N Herndon; Allan R Brasier
Journal:  J Invest Dermatol       Date:  2013-01-10       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.